Kexing Bioproduct

Kexing Biopharm is a leading Chinese biopharmaceutical company focused on the research, development, production, and sales of recombinant protein therapeutics and glandular micro-ecological preparations. The company has established a strong market presence with its core products, including recombinant human erythropoietin (EPOGEN), recombinant human interferon alfa-2b (SINOGEN), and recombinant human granulocyte colony-stimulating factor (WHITEGEN). Kexing Biopharm operates high-standard manufacturing facilities and maintains an extensive distribution network covering thousands of hospitals across China and dozens of international markets. In recent years, the company has aggressively expanded its pipeline into oncology and immunology through the development and licensing of biosimilars and innovative biologics.